Diaphorina citri psyllid: psy6862

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
NAD-dependent protein deacetylase sir-2.1	NAD-dependent deacetylase (By similarity). Functions upstream of daf-16 in the insulin-like signaling pathway, promoting daf-16 mediated transcriptional activation and increased life-span. May also regulate life-span independently of daf-16 by modulating the transcription of genes involved in the stress response of the endoplasmic reticulum (ER).	confident	Q21921
NAD-dependent deacetylase sir2D	NAD-dependent deacetylase, which plays an important role in the regulation of transcriptional repression.	confident	Q54GV7
NAD-dependent histone deacetylase Sir2	NAD-dependent histone deacetylase involved in heterochromatic silencing. Mildly suppresses the heterochromatin-mediated silencing phenomenon known as position-effect variegation (PEV). Required for epigenetic silencing of the polycomb group proteins. Has histone H4 deacetylase activity in vitro. Required maternally for establishing proper segmentation of the embryo. Involved in sex determination. May be involved in the regulation of life span.	confident	Q9VK34

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0070932 [BP]	histone H3 deacetylation	probable	GO:0006476, GO:0044699, GO:0044267, GO:0044260, GO:0006325, GO:0071840, GO:0016043, GO:0016575, GO:0071704, GO:0016570, GO:0035601, GO:0009987, GO:0006464, GO:0043412, GO:0036211, GO:0044763, GO:0008152, GO:0006996, GO:0044238, GO:0051276, GO:0019538, GO:0044237, GO:0043170, GO:0008150, GO:0016568, GO:0016569
GO:0006281 [BP]	DNA repair	probable	GO:0090304, GO:0034641, GO:0006807, GO:0044699, GO:0006139, GO:0051716, GO:0044260, GO:0071704, GO:1901360, GO:0009987, GO:0006725, GO:0006974, GO:0006950, GO:0044763, GO:0008152, GO:0046483, GO:0044238, GO:0050896, GO:0044237, GO:0043170, GO:0033554, GO:0006259, GO:0008150
GO:0002821 [BP]	positive regulation of adaptive immune response	probable	GO:0050776, GO:0048584, GO:0048583, GO:0050778, GO:0002819, GO:0008150, GO:0002684, GO:0002682, GO:0048518, GO:0065007, GO:0050789
GO:0016605 [CC]	PML body	probable	GO:0044446, GO:0016604, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0005575, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422
GO:0035098 [CC]	ESC/E(Z) complex	probable	GO:0031974, GO:0043229, GO:0035097, GO:0043227, GO:0043226, GO:0034708, GO:0005575, GO:0031519, GO:0031981, GO:0005634, GO:0005654, GO:0044451, GO:0043234, GO:0032991, GO:0043231, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0044428, GO:0044424, GO:0044422
GO:0051128 [BP]	regulation of cellular component organization	probable	GO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0005720 [CC]	nuclear heterochromatin	probable	GO:0031974, GO:0043229, GO:0043228, GO:0000785, GO:0000228, GO:0043227, GO:0043226, GO:0005575, GO:0031981, GO:0005634, GO:0044454, GO:0005694, GO:0000792, GO:0000790, GO:0043231, GO:0043232, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0044428, GO:0044424, GO:0044427, GO:0044422
GO:0032088 [BP]	negative regulation of NF-kappaB transcription factor activity	probable	GO:0080090, GO:0019222, GO:0031326, GO:0031323, GO:0050789, GO:2000112, GO:0060255, GO:0065007, GO:0044092, GO:0065009, GO:0010468, GO:0019219, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:2001141, GO:0043433, GO:0051090, GO:0051252, GO:0006355, GO:0010556
GO:0005737 [CC]	cytoplasm	probable	GO:0044424, GO:0005575, GO:0044464, GO:0005623, GO:0005622
GO:2000757 [BP]	negative regulation of peptidyl-lysine acetylation	probable	GO:0009892, GO:0080090, GO:0019222, GO:0031324, GO:0031323, GO:0050789, GO:0051248, GO:0010605, GO:0051246, GO:0065007, GO:0031399, GO:0048519, GO:0060255, GO:0050794, GO:1901984, GO:0008150, GO:1901983, GO:0032269, GO:0032268, GO:0031400, GO:2000756, GO:0048523
GO:0046969 [MF]	NAD-dependent histone deacetylase activity (H3-K9 specific)	probable	GO:0016787, GO:0019213, GO:0003824, GO:0004407, GO:0016810, GO:0016811, GO:0017136, GO:0034979, GO:0032129, GO:0003674, GO:0033558
GO:0031667 [BP]	response to nutrient levels	probable	GO:0009991, GO:0008150, GO:0050896, GO:0009605
GO:0016567 [BP]	protein ubiquitination	probable	GO:0071704, GO:0044267, GO:0044260, GO:0044238, GO:0019538, GO:0009987, GO:0070647, GO:0006464, GO:0043170, GO:0032446, GO:0043412, GO:0036211, GO:0008150, GO:0044237, GO:0008152
GO:0019899 [MF]	enzyme binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0008134 [MF]	transcription factor binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0070301 [BP]	cellular response to hydrogen peroxide	probable	GO:1901700, GO:1901701, GO:0051716, GO:0070887, GO:0042542, GO:0050896, GO:0009987, GO:0034614, GO:0000302, GO:0008150, GO:0006950, GO:0044763, GO:0033554, GO:0042221, GO:0034599, GO:0010035, GO:0006979, GO:0044699
GO:0016239 [BP]	positive regulation of macroautophagy	probable	GO:0032106, GO:0032107, GO:0032104, GO:0032103, GO:0031329, GO:0032101, GO:0009896, GO:0048584, GO:0031323, GO:0009894, GO:0032109, GO:0010647, GO:0010646, GO:0050789, GO:0009893, GO:0019222, GO:0010508, GO:0065007, GO:0048518, GO:0010506, GO:0031325, GO:0016241, GO:0031331, GO:0048583, GO:0050794, GO:0008150, GO:0080134, GO:0080135, GO:0048522
GO:0001525 [BP]	angiogenesis	probable	GO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0048514, GO:0048646, GO:0048731, GO:0008150, GO:0009653, GO:0007275, GO:0044699
GO:0046628 [BP]	positive regulation of insulin receptor signaling pathway	probable	GO:0023051, GO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0046626, GO:0050794, GO:0023056, GO:0065007, GO:0008150, GO:1900076, GO:0048518, GO:1900078, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:0005719 [CC]	nuclear euchromatin	probable	GO:0031974, GO:0043229, GO:0043228, GO:0000785, GO:0000228, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0044454, GO:0005694, GO:0000790, GO:0000791, GO:0043231, GO:0043232, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0044424, GO:0044427, GO:0044422
GO:0005677 [CC]	chromatin silencing complex	probable	GO:0043234, GO:0005575, GO:0032991, GO:0043231, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0043229, GO:0044428, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0043124 [BP]	negative regulation of I-kappaB kinase/NF-kappaB cascade	probable	GO:0009968, GO:0008150, GO:0009966, GO:0048585, GO:0048583, GO:0048519, GO:0050794, GO:0050789, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048523, GO:0010646, GO:0010627, GO:0010741, GO:0043122
GO:0008630 [BP]	intrinsic apoptotic signaling pathway in response to DNA damage	probable	GO:0097190, GO:0097193, GO:0023052, GO:0007165, GO:0007569, GO:0035556, GO:0044699, GO:0051716, GO:0050789, GO:0065007, GO:0010259, GO:0006915, GO:0009987, GO:0050794, GO:0006974, GO:0012501, GO:0006950, GO:0008150, GO:0007154, GO:0044700, GO:0050896, GO:0033554, GO:0044763
GO:0033553 [CC]	rDNA heterochromatin	probable	GO:0044446, GO:0005575, GO:0043232, GO:0044464, GO:0005623, GO:0005622, GO:0000792, GO:0043229, GO:0043228, GO:0000785, GO:0044424, GO:0044427, GO:0005694, GO:0043226, GO:0044422
GO:0000781 [CC]	chromosome, telomeric region	probable	GO:0005575, GO:0043232, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0043229, GO:0043228, GO:0044424, GO:0044427, GO:0005694, GO:0043226, GO:0044422
GO:0034983 [BP]	peptidyl-lysine deacetylation	probable	GO:0071704, GO:0044267, GO:0035601, GO:0044260, GO:0044238, GO:0018205, GO:0044237, GO:0009987, GO:0006464, GO:0006476, GO:0019538, GO:0043412, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0043170
GO:0005730 [CC]	nucleolus	probable	GO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0034391 [BP]	regulation of smooth muscle cell apoptotic process	probable	GO:0050794, GO:0043067, GO:0065007, GO:0010660, GO:0008150, GO:0010941, GO:0042981, GO:0050789
GO:0005637 [CC]	nuclear inner membrane	probable	GO:0005575, GO:0016020, GO:0031090, GO:0005623, GO:0031965, GO:0005634, GO:0005635, GO:0019866, GO:0031967, GO:0005622, GO:0044446, GO:0043229, GO:0044428, GO:0012505, GO:0044424, GO:0044464, GO:0031975, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0043167 [MF]	ion binding	probable	GO:0003674, GO:0005488
GO:2000774 [BP]	positive regulation of cellular senescence	probable	GO:0090342, GO:0090343, GO:0051094, GO:0050793, GO:0080134, GO:0048584, GO:0048583, GO:0050794, GO:0065007, GO:0080135, GO:0048518, GO:0008150, GO:2000772, GO:0050789, GO:0048522
GO:2000773 [BP]	negative regulation of cellular senescence	probable	GO:0051093, GO:0090342, GO:0090344, GO:0050793, GO:0048585, GO:0080135, GO:0048583, GO:0050794, GO:0008150, GO:0080134, GO:0065007, GO:0048519, GO:2000772, GO:0050789, GO:0048523
GO:0032868 [BP]	response to insulin stimulus	probable	GO:1901700, GO:0009719, GO:0050896, GO:0009725, GO:0010243, GO:1901698, GO:0008150, GO:1901652, GO:0042221, GO:0043434, GO:0010033
GO:2000480 [BP]	negative regulation of cAMP-dependent protein kinase activity	probable	GO:0033673, GO:0051348, GO:0019220, GO:0080090, GO:0019222, GO:2000479, GO:0044092, GO:0031324, GO:0031323, GO:0009892, GO:0071901, GO:0071900, GO:0043086, GO:0051248, GO:0010605, GO:0010563, GO:0051246, GO:0050789, GO:0065007, GO:0043549, GO:0031399, GO:0048519, GO:0065009, GO:0006469, GO:0045936, GO:0060255, GO:0050790, GO:0050794, GO:0051174, GO:0045859, GO:0042326, GO:0008150, GO:0042325, GO:0032269, GO:0032268, GO:0031400, GO:0051338, GO:0001933, GO:0001932, GO:0048523
GO:0030512 [BP]	negative regulation of transforming growth factor beta receptor signaling pathway	probable	GO:0090287, GO:0009968, GO:0090101, GO:0009966, GO:0048583, GO:0048585, GO:0017015, GO:0090288, GO:0050794, GO:0090092, GO:0023057, GO:0065007, GO:0010648, GO:0008150, GO:0023051, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0007346 [BP]	regulation of mitotic cell cycle	probable	GO:0008150, GO:0050794, GO:0065007, GO:0050789, GO:0051726
GO:0071356 [BP]	cellular response to tumor necrosis factor	probable	GO:0051716, GO:0034097, GO:0071345, GO:0050896, GO:0034612, GO:0009987, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0031648 [BP]	protein destabilization	probable	GO:0019222, GO:0060255, GO:0010608, GO:0031647, GO:0050789, GO:0065007, GO:0008150, GO:0065008, GO:0010468
GO:0045348 [BP]	positive regulation of MHC class II biosynthetic process	probable	GO:0045346, GO:0009893, GO:0019222, GO:0009891, GO:0060255, GO:0009889, GO:0010557, GO:0010556, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0010604
GO:0006343 [BP]	establishment of chromatin silencing	probable	GO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0040029, GO:0010629, GO:0050789, GO:0044699, GO:0010605, GO:0019222, GO:0006325, GO:0006342, GO:2000112, GO:2000113, GO:0016043, GO:0008150, GO:0019219, GO:0016458, GO:0065007, GO:0071840, GO:0048519, GO:0045814, GO:0010468, GO:0045934, GO:0060255, GO:0009987, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0006996, GO:0051276, GO:0006338, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0048523, GO:0044763, GO:0010558, GO:0016568
GO:0051097 [BP]	negative regulation of helicase activity	probable	GO:0051336, GO:0051346, GO:0051095, GO:0065009, GO:0050790, GO:0050789, GO:0065007, GO:0044092, GO:0008150, GO:0019222, GO:0043086
GO:0045944 [BP]	positive regulation of transcription from RNA polymerase II promoter	probable	GO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0000183 [BP]	chromatin silencing at rDNA	probable	GO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0040029, GO:0010629, GO:0050789, GO:0044699, GO:0010605, GO:0019222, GO:0006342, GO:2000112, GO:2000113, GO:0008150, GO:0060255, GO:0016458, GO:0065007, GO:0048519, GO:0045814, GO:0010468, GO:0045934, GO:0019219, GO:0009987, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0044763, GO:0010558, GO:0048523
GO:0043518 [BP]	negative regulation of DNA damage response, signal transduction by p53 class mediator	probable	GO:0010646, GO:0009968, GO:0023057, GO:0009966, GO:0050789, GO:0048585, GO:0080135, GO:0048583, GO:0050794, GO:0023051, GO:2001021, GO:0065007, GO:0048519, GO:0008150, GO:1901796, GO:1901797, GO:2001020, GO:0043516, GO:0080134, GO:0048523, GO:0010648

Prediction of Enzyme Commission Number

No confident prediction of EC number!

Spatial Structural Prediction